Antibody Drug Conjugates Market Competitive Landscape and Innovation Outlook 2031
The Antibody Drug Conjugates Market is gaining momentum as targeted oncology becomes increasingly important in precision medicine. ADCs offer a platform for combining biological targeting with highly potent therapeutic payloads. The Antibody Drug Conjugates Market size is projected to reach US$ 38,077.45 million by 2031 from US$ 8,105.65 million in 2023, registering an estimated CAGR of 21.3%...
0 Σχόλια 0 Μοιράστηκε